Author

Bincy P. Abraham

OZANIMOD IS AN EFFECTIVE ORAL TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS REGARDLESS OF MODERATE OR SEVERE ENDOSCOPIC DISEASE ACTIVITY: A POST HOC ANALYSIS OF TRUE NORTH
OZANIMOD IS AN EFFECTIVE ORAL TREATMENT FOR PATIENTS WITH ULCERATIVE COLITIS REGARDLESS OF MODERATE OR SEVERE ENDOSCOPIC DISEASE ACTIVITY: A POST HOC ANALYSIS OF TRUE NORTH

Bincy P. Abraham  et al.

DURABILITY OF OZANIMOD RESPONSE BY BASELINE ENDOSCOPIC DISEASE ACTIVITY IN ADVANCED THERAPY–NAIVE PATIENTS WITH ULCERATIVE COLITIS UNCONTROLLED ON CONVENTIONAL THERAPIES: INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
DURABILITY OF OZANIMOD RESPONSE BY BASELINE ENDOSCOPIC DISEASE ACTIVITY IN ADVANCED THERAPY–NAIVE PATIENTS WITH ULCERATIVE COLITIS UNCONTROLLED ON CONVENTIONAL THERAPIES: INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION

Bincy P. Abraham  et al.

CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION
CORRELATION BETWEEN SERUM ANTI-TNF TROUGH CONCENTRATIONS AND TRANSMURAL DAMAGE IN CROHN’S DISEASE PATIENTS IN LONG STANDING AND STABLE CLINICAL REMISSION

Bincy P. Abraham  et al.

Item 1 - 3 / 3
1